Growth Plus Reports Logo.jpg
Trastuzumab Biosimilars Market Anticipates a Reach of US$ 17.90 billion by 2031, Propelled by an 27.3% CAGR | Growth Plus Reports
25 janv. 2024 07h30 HE | Growth Plus Reports
Pune, Jan. 25, 2024 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Trastuzumab Biosimilars Market is expected to clock US$ 17.90 billion by 2031 and...